This is just a bad argument you keep on posting. The contract between UCLA and NWBO is for all improvements or iterations. You are also ignoring prior patent art. And most of all you ignore presentations by the UCLA staff saying it is DC-Vax and that NWBO has the commercial production rights.
Market Data 
Markets 
AI
